We're unlocking novel biology and creating better biologics with AI
We're unlocking novel biology and creating better biologics with AI
We're advancing a robust pipeline of internal and partnered programs designed with generative AI
Designing Differentiated Biologics with AI
Our Integrated Drug Creation Platform designed a differentiated TL1A antibody with potential best-in-class profile for Inflammatory Bowel Disease.
Read how we are going from conception to the clinic in 24 months.
Absci exists to create better biologics for patients, faster
Historically, biologics drug discovery has been a long, expensive process with a high failure rate. Absci is uncovering novel biology to create better biologics from scratch with AI, and ultimately get life-changing medicines to patients.
Partner with Absci
Absci partners with leaders across pharma, tech, and academia to develop differentiated biologics against challenging targets using generative AI
AI Drug Creation
Our wet lab and AI work in iterative cycles to build AI models that unlock differentiated biology and design better biologics, faster
Data generation & model training
De novo design of biologics
Multi-parametric lead optimization
Data to train, AI to create, and wet lab to validate with 6 week cycle times
AI Target Discovery
AI-enabled novel target discovery using Reverse Immunology
Our AI technology for novel target discovery leverages reverse immunology to identify antibodies produced by super immune responders. Our approach gives us an antibody/target pair ready for AI optimization and IND-enabling studies.
Track record of industry-leading collaborations
careers
Join us
From scientists to data engineers, we're all part of the drug creation process
